Back to Search
STEVEN FOUNG, MD
MD
Anatomic Pathology & Clinical Pathology Physician
NPI: 1548325152Individual
Specialties, Licenses & Credentials
Anatomic Pathology Physician
Pathology — Anatomic Pathology
Code: 207ZP0101X
G32807(CA)
Pediatrics Physician
Pediatrics
Code: 208000000X
G32807(CA)
Anatomic Pathology & Clinical Pathology PhysicianPrimary
Pathology — Anatomic Pathology & Clinical Pathology
Code: 207ZP0102X
G32807(CA)
Research & Publications (20)
Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein.
PMID 18272755·J Gen Virol·2008
8-other
Antigen-specific proteolysis by hybrid antibodies containing promiscuous proteolytic light chains paired with an antigen-binding heavy chain.
PMID 19542217·J Biol Chem·2009
7-preclinical
Mutations in hepatitis C virus E2 located outside the CD81 binding sites lead to escape from broadly neutralizing antibodies but compromise virus infectivity.
PMID 19321602·J Virol·2009
8-other
CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells.
PMID 19088272·J Gen Virol·2009
8-other
In vitro selection of a neutralization-resistant hepatitis C virus escape mutant.
PMID 19052239·Proc Natl Acad Sci U S A·2008
8-other
Hepatitis C virus (HCV)-induced immunoglobulin hypermutation reduces the affinity and neutralizing activities of antibodies against HCV envelope protein.
PMID 18417597·J Virol·2008
8-other
Definition of a conserved immunodominant domain on hepatitis C virus E2 glycoprotein by neutralizing human monoclonal antibodies.
PMID 18400849·J Virol·2008
8-other
A point mutation leading to hepatitis C virus escape from neutralization by a monoclonal antibody to a conserved conformational epitope.
PMID 18385242·J Virol·2008
8-other
Structural elucidation of critical residues involved in binding of human monoclonal antibodies to hepatitis C virus E2 envelope glycoprotein.
PMID 18230369·Biochim Biophys Acta·2008
8-other
Antibody-dependent enhancement of hepatitis C virus infection.
PMID 18094180·J Virol·2008
7-preclinical
Therapeutic control of hepatitis C virus: the role of neutralizing monoclonal antibodies.
PMID 17990788·Curr Top Microbiol Immunol·2008
6-review
The neutralizing activity of anti-hepatitis C virus antibodies is modulated by specific glycans on the E2 envelope protein.
PMID 17522218·J Virol·2007
8-other
Immunogenic and functional organization of hepatitis C virus (HCV) glycoprotein E2 on infectious HCV virions.
PMID 17079294·J Virol·2007
8-other
High density lipoprotein inhibits hepatitis C virus-neutralizing antibodies by stimulating cell entry via activation of the scavenger receptor BI.
PMID 16675450·J Biol Chem·2006
7-preclinical
Preclinical evaluation of two neutralizing human monoclonal antibodies against hepatitis C virus (HCV): a potential treatment to prevent HCV reinfection in liver transplant patients.
PMID 16501075·J Virol·2006
7-preclinical
Hepatitis C virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon and interleukin-6.
PMID 16378988·J Virol·2006
8-other
Analysis of a highly flexible conformational immunogenic domain a in hepatitis C virus E2.
PMID 16227243·J Virol·2005
4-observational
Folding and dimerization of hepatitis C virus E1 and E2 glycoproteins in stably transfected CHO cells.
PMID 15661174·Virology·2005
7-preclinical
Antibody light chain-catalyzed hydrolysis of a hepatitis C virus peptide.
PMID 15357986·Bioorg Med Chem Lett·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 3373 Hillview Avenue
Palo Alto, CA 94304 - Phone
- (650) 723-6481
Quick Facts
- NPI
- 1548325152
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 3
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile